Incannex Healthcare (IXHL) Current Assets (2020 - 2026)
Incannex Healthcare (IXHL) posted quarterly Current Assets of $80.1 million for Q1 2026, up 412.48% year-on-year from $15.6 million in Q1 2025, and up 7.25% on a QoQ basis from $74.7 million in Q4 2025.
Incannex Healthcare (IXHL) Current Assets (2020 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Current Assets for 7 consecutive years, with $80.1 million the latest figure, recorded in Q1 2026.
- Quarterly Current Assets rose 412.48% year-over-year to $80.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $80.1 million (up 412.48% YoY) and the FY2025 annual result came in at $20.0 million, up 23.21% from the prior year.
- Current Assets advanced to $80.1 million in Q1 2026 per IXHL's latest filing, from $74.7 million in the prior quarter.
- Over the last five years, Current Assets for IXHL reached as high as $80.1 million in Q1 2026 and fell as low as $10.5 million in Q4 2024.
- A 5-year average of $34.7 million and a median of $21.3 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets sank 50.76% — and 2025, when it soared 610.95%.
- Year by year, Current Assets stood at $42.1 million in 2022, then slumped by 49.37% to $21.3 million in 2023, then plunged by 50.76% to $10.5 million in 2024, then surged by 610.95% to $74.7 million in 2025, then advanced by 7.25% to $80.1 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $80.1 million, $74.7 million, and $78.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | 80.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.10 Mn |
| Dec 31, 2025 | 74.68 Mn |
| Sep 30, 2025 | 78.30 Mn |
| Jun 30, 2025 | 19.96 Mn |
| Mar 31, 2025 | 15.63 Mn |
| Dec 31, 2024 | 10.50 Mn |
| Sep 30, 2024 | 15.21 Mn |
| Jun 30, 2024 | 16.20 Mn |
| Mar 31, 2024 | 16.32 Mn |
| Dec 31, 2023 | 21.33 Mn |
| Jun 30, 2023 | 23.00 Mn |
| Dec 31, 2022 | 42.13 Mn |
| Jun 30, 2022 | 37.88 Mn |
| Jun 30, 2021 | 9.33 Mn |
| Jun 30, 2020 | 4.24 Mn |